✉ Email this page to a colleague
« Back to Dashboard
Putrescine is an investigational drug.
There have been 7 clinical trials for Putrescine. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Hypersensitivity, and Colorectal Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Associazione Oncologia Traslazionale, and Thomas E. Ahlering.
There are one hundred and thirty-two US patents protecting this investigational drug and twenty-seven international patents.
Recent Clinical Trials for Putrescine
|Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis||BioGaia AB||Phase 4|
|Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis||University of Zagreb||Phase 4|
|Feasibility Study on Stem Cells Sensitivity Assay||Associazione Oncologia Traslazionale||Phase 2|
Top disease conditions for Putrescine
Top clinical trial sponsors for Putrescine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Putrescine||⤷ Try a Trial||Acylated amine compounds which are useful fungicigal agents||Roussel Uclaf (Paris, FR)||⤷ Try a Trial|
|Putrescine||⤷ Try a Trial||Liquid developer for electrostatic photography||Fuji Photo Film Co., Ltd. (Kanagawa, JP)||⤷ Try a Trial|
|Putrescine||⤷ Try a Trial||Method for quantitative determination of polyamines||Tokuyama Soda Co., Ltd. (Tokuyama, JP)||⤷ Try a Trial|
|Putrescine||⤷ Try a Trial||Process for producing unsaturated mono and dicarboxylic acid imide compound||Matsushita Electric Works Ltd. (Osaka, JP)||⤷ Try a Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Putrescine||European Patent Office||EP0325258||2008-01-20||⤷ Try a Trial|
|Putrescine||Japan||JPH01185667||2008-01-20||⤷ Try a Trial|
|Putrescine||Germany||DE69016062||2009-03-06||⤷ Try a Trial|
|Putrescine||European Patent Office||EP0386544||2009-03-06||⤷ Try a Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|